Elizabeth G Nabel Accolade, Inc. (ACCD) insider trading activity

Elizabeth G Nabel is Director of Accolade, Inc.. Currently has a direct ownership of 39,804 shares of ACCD, which is worth approximately $140,906. The most recent transaction as insider was on Dec 02, 2024, when has been sold 2,179 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.8K

5.79% 3M change

78.33% 12M change

Total Value Held $140,906

ELIZABETH G NABEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	BUY Exercise of conversion of derivative security	-	2,179 Added 5.19%	39,804 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	2,179 Added 5.47%	37,625 Common Stock
Aug 06 2024	BUY Exercise of conversion of derivative security	-	9,196 Added 20.6%	35,446 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	2,179 Added 7.66%	26,250 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	1,751 Added 6.78%	24,071 Common Stock
Nov 30 2023	BUY Exercise of conversion of derivative security	-	1,751 Added 7.27%	22,320 Common Stock
Aug 31 2023	BUY Exercise of conversion of derivative security	-	1,752 Added 7.85%	20,569 Common Stock
Jul 25 2023	BUY Exercise of conversion of derivative security	-	14,060 Added 42.77%	18,817 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	-	1,752 Added 26.92%	4,757 Common Stock
Jul 21 2022	BUY Exercise of conversion of derivative security	-	2,659 Added 46.95%	3,005 Common Stock
Jul 22 2021	BUY Exercise of conversion of derivative security	-	346 Added 50.0%	346 Common Stock

Also insider at

MDT

Medtronic plc Healthcare

Director

MRNA

Moderna, Inc. Healthcare

Director

LYEL

Lyell Immunopharma, Inc. Healthcare

EGN